Skip to main content

Medical Treatments: Innovation

Question for Department of Health

UIN 60450, tabled on 17 January 2017

To ask the Secretary of State for Health, what discussions he has had with clinical representatives bodies on the Commissioning through Evaluation process; and if he will make a statement.

Answered on

25 January 2017

NHS England’s Commissioning through Evaluation (CtE) programme was established in direct response to national clinical experts identifying treatments that, whilst not currently routinely funded by the National Health Service due to inadequate evidence of relative clinical and/or cost effectiveness, nonetheless showed significant promise for the future.

The CtE programme is therefore specifically designed to generate new valuable evaluative data that would otherwise not be available from current or planned clinical (research) trials, so that it can be considered in future reviews of published clinical commissioning policy.

Potential new schemes are identified by NHS England’s clinical reference groups which include representation from professional clinical representative bodies as well as national clinical and patient experts in over 40 specialised service and specialty areas.